BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10797917)

  • 1. [Aids neurologic manifestations in childhood].
    Rotta NT; Silva C; Ohlweiler L; Lago I; Cabral R; Gonçalves F; Almeida AM; Khan R; Mello L; Ranzan J; Guedes F
    Rev Neurol; 1999 Aug 16-31; 29(4):319-22. PubMed ID: 10797917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Acquired immunodeficiency syndrome by vertical transmission: neurological disorders].
    Tellechea-Rotta N; Legido A
    Rev Neurol; 2003 Feb 1-15; 36(3):255-63. PubMed ID: 12599156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Encephalopathy in children infected by vertically transmitted human immunodeficiency virus].
    Czornyj LA
    Rev Neurol; 2006 Jun 16-30; 42(12):743-53. PubMed ID: 16775801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuro-AIDS].
    Tellechea N; da Silva CL; Colvero M; Schirmer M; Afonso-Galvão N
    Rev Neurol; 1997 Jun; 25(142):903-5. PubMed ID: 9244626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.
    McArthur JC; McDermott MP; McClernon D; St Hillaire C; Conant K; Marder K; Schifitto G; Selnes OA; Sacktor N; Stern Y; Albert SM; Kieburtz K; deMarcaida JA; Cohen B; Epstein LG
    Arch Neurol; 2004 Nov; 61(11):1687-96. PubMed ID: 15534180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nervous system manifestations in HIV infected children].
    Funk M; Joseph-Steiner J; Hernaiz-Driever P; Mentzer D; Göhlich-Ratmann G; Bollinger M; Kreuz W; Kornhuber B; Jacobi G
    Klin Padiatr; 1996; 208(5):299-303. PubMed ID: 8992098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HIV infection in childhood].
    Zenz W
    Padiatr Padol; 1993; 28(3):A19-26. PubMed ID: 8367174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuro-cognitive disorders on the rise.
    Link D
    GMHC Treat Issues; 1995 Mar; 9(3):7-8. PubMed ID: 11362361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and risk factors for HIV encephalopathy in children.
    Hamid MZ; Aziz NA; Zulkifli ZS; Norlijah O; Azhar RK
    Southeast Asian J Trop Med Public Health; 2008 Mar; 39(2):266-72. PubMed ID: 18564712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological and developmental effects of HIV and AIDS in children and adolescents.
    Mitchell W
    Ment Retard Dev Disabil Res Rev; 2001; 7(3):211-6. PubMed ID: 11553937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neurologic manifestations in pediatric patients with AIDS].
    Samudio-Domínguez G; Dávila G; Martínez-Aguilar G; Santos-Preciado JI
    Bol Med Hosp Infant Mex; 1992 Sep; 49(9):558-65. PubMed ID: 1388779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 encephalopathy among perinatally infected children: Neuropathogenesis and response to highly active antiretroviral therapy.
    Mitchell CD
    Ment Retard Dev Disabil Res Rev; 2006; 12(3):216-22. PubMed ID: 17061285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk and resilience in the cognitive functioning of children born to HIV-1-infected mothers: a preliminary report.
    Coscia JM; Christensen BK; Henry RR
    Pediatr AIDS HIV Infect; 1997 Apr; 8(2):108-13. PubMed ID: 11361776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognitive outcomes in pediatric HIV.
    Willen EJ
    Ment Retard Dev Disabil Res Rev; 2006; 12(3):223-8. PubMed ID: 17061290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of vitamins, including vitamin A, on HIV/AIDS patients.
    Mehta S; Fawzi W
    Vitam Horm; 2007; 75():355-83. PubMed ID: 17368322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recommendations of GESIDA (Grupo de Estudio de SIDA)/National Plan on AIDS with respect to the anti-retroviral treatment in adult patients infected with the human immunodeficiency virus in the year 2000 (II)].
    Miró JM; Antela A; Arrizabalaga J; Clotet B; Gatell JM; Guerra L; Antonio Iribarren J; Laguna F; Moreno S; Parras F; Rubio R; Santamaría JM; Viciana P;
    Enferm Infecc Microbiol Clin; 2000 Oct; 18(8):396-412. PubMed ID: 11153204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Course and treatment of progressive subacute encephalopathy caused by human immunodeficiency virus in children. The value of Botulinum toxin].
    Noguera-Julian A; Pérez-Dueñas B; Fortuny-Guasch C; López-Casas J; Póo P
    Rev Neurol; 2004 Feb 1-15; 38(3):239-43. PubMed ID: 14963851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mother to child transmission of infantile HIV/AIDS in Cuba].
    González Núñez I; Díaz Jidy M; Pérez Avila J
    Rev Cubana Med Trop; 2000; 52(3):220-4. PubMed ID: 11826527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART).
    Chiriboga CA; Fleishman S; Champion S; Gaye-Robinson L; Abrams EJ
    J Pediatr; 2005 Mar; 146(3):402-7. PubMed ID: 15756229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuro-psychiatric manifestations of acquired immune deficiency syndrome (AIDS).
    Abiodun OA
    Cent Afr J Med; 1990 Sep; 36(9):224-30. PubMed ID: 2285934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.